-
241
Repression of the stress granule protein G3BP2 inhibits immune checkpoint molecule PD‐L1
Published 2025-02-01“…In this study, we show that this protein also upregulates the immune checkpoint molecule PD‐L1 under conditions of stress in breast and glioblastoma cancer cells, revealing a previously unknown connection between stemness programs, stress responses, and immune checkpoint control. …”
Get full text
Article -
242
Aqp 9 and Brain Tumour Stem Cells
Published 2012-01-01“…We, therefore, propose that aquaporin 9 may have a central role in the tumorigenesis of glioblastoma.…”
Get full text
Article -
243
Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention
Published 2012-01-01“…Immunotherapy is making inroads towards effectively treating other fatal cancers, such as melanoma, glioblastoma multiforme, and castrate-resistant prostate cancers. …”
Get full text
Article -
244
Gliosarcoma with Primary Skull Base Invasion
Published 2016-01-01“…Gliosarcoma is an uncommon variant of glioblastoma, which commonly demonstrates dural attachment. …”
Get full text
Article -
245
Trace elements‐based Auroshell gold@hematite nanostructure: Green synthesis and their hyperthermia therapy
Published 2023-02-01“…Cytotoxicity of Auroshell iron@gold nanoparticles against normal HUVEC cells and glioblastoma cancer cells was evaluated by 2,5‐diphenyl‐2H‐tetrazolium bromide method, water bath hyperthermia, and combined method of water bath hyperthermia and nano‐therapy. …”
Get full text
Article -
246
Network analyses of brain tumor multiomic data reveal pharmacological opportunities to alter cell state transitions
Published 2025-02-01“…Abstract Glioblastoma Multiforme (GBM) remains a particularly difficult cancer to treat, and survival outcomes remain poor. …”
Get full text
Article -
247
Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024)
Published 2024-12-01“…Its overexpression has been implicated in the pathogenesis of several cancers, including glioblastoma and colorectal, lung, renal, and bladder cancers, primarily through the increased production of reactive oxygen species (ROS). …”
Get full text
Article -
248
Comparative analysis of the profile of circulating microRNAs in the blood plasma of patients with gliomas
Published 2024-06-01“…The sample included: 2 cases of oligodendroglioma (grades 2–3), 6 – astrocytomas of 2–4 degrees of malignancy, 7 – glioblastomas of 4 degrees of malignancy, 7 – benign neoplasms (meningiomas), 4 – control (conditionally healthy donors).Results. …”
Get full text
Article -
249
The Development and Applications of a Dual Optical Imaging System for Studying Glioma Stem Cells
Published 2019-09-01“…Glioblastoma multiforme represents one of the deadliest brain tumor types, manifested by a high rate of recurrence and poor prognosis. …”
Get full text
Article -
250
Repeated 5-aminolevulinic acid mediated sonodynamic therapy using magnetic resonance guided focused ultrasound in rat brain tumour models
Published 2025-01-01“…Our study aimed to optimize ultrasound parameters for sonodynamic therapy (SDT) with 5-ALA as a sonosensitizing agent and to evaluate its therapeutic outcome on the rodent 9L gliosarcoma and the human U87 glioblastoma models. We stereotactically implanted brain tumour cells in rats and monitored tumour volume via MRI. …”
Get full text
Article -
251
Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells: Effects on Autophagy and NRF2 Pathway
Published 2024-12-01“…These findings highlight the therapeutic potential of CBD, suggesting that modulating NRF2 and autophagy pathways could represent a promising strategy for glioblastoma treatment.…”
Get full text
Article -
252
Preliminary in vitro evaluation of the anti-proliferative activity of guanylhydrazone derivatives
Published 2016-03-01“…Different human tumor cell lines, by including HCT-8 (colon carcinoma), MDA-MB-435 (melanoma) and SF-295 (glioblastoma) were continuous exposed to guanylhydrazone derivatives for 72 hours and growth inhibition of tumor cell lines and macrophages J774 was measured using tetrazolium salt (MTT) assay. …”
Get full text
Article -
253
Enolase inhibitors as therapeutic leads for Naegleria fowleri infection.
Published 2024-08-01“…Recently, human enolase 2 (ENO2) phosphonate inhibitors have been developed as lead agents to treat glioblastoma multiforme (GBM). These compounds, which cure GBM in a rodent model, are well-tolerated in mammals because enolase 1 (ENO1) is the predominant isoform used systemically. …”
Get full text
Article -
254
Comprehensive single-cell pan-cancer atlas unveils IFI30+ macrophages as key modulators of intra-tumoral immune dynamics
Published 2025-01-01“…Pan-cancer analyses and glioblastoma multiforme (GBM) investigations collectively underscore IFI30's potential as a TME modulator, particularly in its interaction with M2-macrophages. …”
Get full text
Article -
255
Comparative analysis of lactaptin activity when produced in bacterial or eukaryotic expression systems
Published 2017-12-01“…Next, we measured the cytotoxic effects of the media conditioned by pEL1-transfected HEK293T cells, as assayed against the panel of three human cancer cell lines: MDA-MB-231 (adenocarcinoma), PC3 (prostate cancer), and T98G (glioblastoma). We show that EL1-derived lactaptin is at least 100-fold more cytotoxic than RL2. …”
Get full text
Article -
256
The role of VANGL2 in glioma oncogenesis and progression: insights into expression profiles and prognostic relevance
Published 2025-01-01“…Furthermore, rigorous methodologies were employed in survival analysis to control for confounding factors.ResultsWe identified substantial upregulation of VANGL2 gene in both low-grade glioma (LGG) and glioblastoma (GBM). Functional enrichment analysis of genes positively associated with VANGL2 in glioma underscored their enrichment in Notch signaling and pathway regulating pluripotency of stem cells. …”
Get full text
Article -
257
Single-cell sequencing elucidates the mechanism of NUSAP1 in glioma and its diagnostic and prognostic significance
Published 2025-02-01“…In-depth exploration of NUSAP1’s mechanisms in glioblastoma could enhance our understanding of its response to immunotherapy, suggesting that targeting NUSAP1 may offer therapeutic benefits for glioma patients.…”
Get full text
Article -
258
Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy
Published 2025-02-01“…Abstract Background Glioma, particularly glioblastoma (GBM), is a highly aggressive tumor with limited responsiveness to immunotherapy. …”
Get full text
Article -
259
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Published 2025-02-01“…TNG908 is being tested clinically in patients with MTAP-deleted tumors, including glioblastoma, in a Phase I/II clinical trial (NCT05275478).…”
Get full text
Article -
260
Sphingosine kinase 1 promotes M2 macrophage infiltration and enhances glioma cell migration via the JAK2/STAT3 pathway
Published 2025-02-01“…Survival analysis illustrated that patients with high-SPHK1 expression, particularly glioblastoma and IDH-wildtype, tended to have a shorter survival time. …”
Get full text
Article